New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
07:16 EDTAGNAllergan Botox increase could provide incremental upside, says Credit Suisse
Credit Suisse said Allergan's first price in six years for Botox could lead to incremental upside to Street estimates. The firm expects 2014 guidance to be a catalyst for shares and raised estimates and price target to $123 from $112. Shares are Outperform rated.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use